| Issue Date | Title | Author(s) |
| 2014-01-21 | Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse | Lund, ME; O'Brien, BA; Hutchinson, AT; Robinson, MW; Simpson, AM; Dalton, JP; Donnelly, S |
| 2013-01-01 | Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy | Ren, B; O'Brien, BA; Byrne, MR; Ch'ng, E; Gatt, PN; Swan, MA; Nassif, NT; Wei, MQ; Gijsbers, R; Debyser, Z; Simpson, AM |
| 2019-05-01 | Current Status on Immunological Therapies for Type 1 Diabetes Mellitus | Xin, GLL; Khee, YP; Ying, TY; Chellian, J; Gupta, G; Kunnath, AP; Nammi, S; Collet, T; Hansbro, PM; Dua, K; Chellappan, DK |
| 1997-05-01 | Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse | O'Brien, BA; Harmon, BV; Cameron, DP; Allan, DJ |
| 2006-03-01 | A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse | O'Brien, BA; Geng, X; Orteu, CH; Huang, Y; Ghoreishi, M; Zhang, YQ; Bush, JA; Li, G; Finegood, DT; Dutz, JP |
| 2002-02-01 | In situ β cell death promotes priming of diabetogenic CD8 T lymphocytes | Zhang, Y; O'Brien, B; Trudeau, J; Tan, R; Santamaria, P; Dutz, JP |
| 2000-05-01 | Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis | O'Brien, BA; Harmon, BV; Cameron, DP; Allan, DJ |
| 2012-12-01 | Lamstatin - a novel inhibitor of lymphangiogenesis derived from collagen IV | Weckmann, M; Moir, LM; Heckman, CA; Black, JL; Oliver, BG; Burgess, JK |
| 2002-01-01 | Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced | O'Brien, BA; Huang, Y; Geng, X; Dutz, JP; Finegood, DT |
